Merete Lund Hetland Selected Research

Janus Kinase Inhibitors

4/2023	Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study.
1/2020	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Merete Lund Hetland Research Topics

Disease

74	Rheumatoid Arthritis 03/2024 - 08/2004
17	Axial Spondyloarthritis 04/2024 - 10/2015
17	Psoriatic Arthritis 04/2024 - 11/2010
15	Rheumatic Diseases (Rheumatism) 12/2023 - 02/2009
14	Arthritis (Polyarthritis) 03/2024 - 04/2008
11	Pain (Aches) 01/2024 - 08/2008
10	Ankylosing Spondylitis 04/2024 - 11/2010
10	Necrosis 03/2024 - 02/2009
10	Fatigue 01/2024 - 08/2008
10	Synovitis 01/2023 - 05/2006
9	Inflammation (Inflammations) 09/2023 - 11/2007
8	Neoplasms (Cancer) 03/2024 - 02/2009
4	Infections 12/2023 - 03/2016
3	Joint Diseases (Joint Disease) 01/2020 - 02/2014
3	Body Weight (Weight, Body) 09/2017 - 05/2006
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 02/2009
1	Knee Osteoarthritis 01/2023
1	COVID-19 01/2023
1	Non-Radiographic Axial Spondyloarthritis 01/2023
1	Adult-Onset Still's Disease 01/2023
1	Neuromyelitis Optica (Devic's Disease) 01/2023
1	Giant Cell Arteritis (Horton Disease) 01/2023
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023
1	Castleman Disease (Castleman's Disease) 01/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023
1	Cytokine Release Syndrome 01/2023
1	Spondylarthritis (Spinal Arthritis) 11/2022
1	Pre-Eclampsia (Preeclampsia) 11/2022
1	Human Influenza (Influenza) 10/2022
1	Acute Coronary Syndrome 01/2022

Drug/Important Bio-Agent (IBA)

26	Antirheumatic Agents (DMARD)IBA 03/2024 - 09/2009
21	Tumor Necrosis Factor InhibitorsIBA 05/2024 - 06/2010
13	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 05/2006
12	Adalimumab (Humira)FDA Link 01/2023 - 08/2006
10	C-Reactive ProteinIBA 04/2024 - 11/2010
10	Abatacept (Orencia)FDA Link 03/2024 - 07/2011
10	ametantrone (HAQ)IBA 01/2024 - 08/2008
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 09/2007
8	Rituximab (Mabthera)FDA Link 03/2024 - 09/2011
8	Infliximab (Remicade)FDA Link 11/2022 - 09/2007
7	tocilizumab (atlizumab)FDA Link 03/2024 - 07/2011
7	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2008
7	Biosimilar PharmaceuticalsIBA 11/2022 - 08/2017
7	Etanercept (Enbrel)FDA Link 01/2020 - 11/2007
6	Anti-Citrullinated Protein AntibodiesIBA 09/2023 - 04/2009
6	Rheumatoid FactorIBA 12/2022 - 08/2011
5	secukinumabIBA 01/2024 - 01/2020
5	GlucocorticoidsIBA 11/2023 - 08/2004
5	AutoantibodiesIBA 01/2021 - 06/2010
3	Prostaglandins AIBA 01/2024 - 10/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2009
3	ORALIT (ORS)IBA 11/2022 - 01/2010
3	AntibodiesIBA 12/2021 - 06/2010
3	Prednisolone (Predate)FDA LinkGeneric 10/2017 - 11/2011
2	Interleukin-17 (Interleukin 17)IBA 03/2024 - 10/2010
2	sarilumabIBA 03/2024 - 01/2020
2	Certolizumab Pegol FDA Link 10/2023 - 01/2020
2	cyclic citrullinated peptideIBA 09/2023 - 04/2009
2	Janus Kinase InhibitorsIBA 04/2023 - 01/2020
2	tofacitinibIBA 01/2023 - 01/2020
2	CytokinesIBA 01/2023 - 10/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 12/2020
2	LipidsIBA 03/2021 - 09/2017
2	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 03/2012
2	CT-P13IBA 01/2018 - 08/2017
2	Triamcinolone (Aristocort)FDA Link 05/2015 - 04/2014
2	Betamethasone (Celestone)FDA Link 06/2012 - 05/2006
2	Peptides (Polypeptides)IBA 06/2012 - 06/2010
2	SteroidsIBA 02/2012 - 09/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2009 - 01/2008
1	InterleukinsIBA 03/2024
1	Interleukin-23 Subunit p19IBA 03/2024
1	Proteins (Proteins, Gene)FDA Link 09/2023
1	apremilastIBA 01/2023
1	Ustekinumab (CNTO 1275)FDA Link 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	ixekizumabIBA 01/2023
1	GP1111IBA 11/2022
1	COVID-19 VaccinesIBA 10/2022
1	GP2017IBA 11/2021
1	LDL CholesterolIBA 03/2021
1	Interferon Type IIBA 01/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2020
1	Leucovorin (Folinic Acid)FDA Link 11/2020
1	baricitinibIBA 01/2020
1	amsonic acid (DAS)IBA 01/2020
1	LigandsIBA 01/2020
1	upadacitinibIBA 01/2020
1	GLPG0634IBA 01/2020
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020
1	Janus KinasesIBA 01/2020
1	golimumab FDA Link 01/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2018

Therapy/Procedure

23	Therapeutics 03/2024 - 08/2004
5	Biological Therapy 12/2023 - 09/2010
3	Injections 05/2015 - 08/2004
2	Drug Tapering 01/2021 - 01/2019
1	Replacement Arthroplasty 01/2023
1	Precision Medicine 01/2023